Skip to main content
TipRanks
Go Ultimate75% OFF

Science (SAG) AI Stock Analysis

6 Followers
GB:SAG

Science

(LSE:SAG)

Select Model
Rating:76Outperform
Price Target:GBX 651.00â–²(17.51% Upside)
Action:reiterated
Date:08/18/26

The overall score reflects a financially robust company with strong margins, a strengthening balance sheet, and generally reliable cash generation, offset by recent revenue plateauing and volatility in profit and free cash flow. Secondary factors include mildly negative short-term technical momentum within a still supportive long-term trend and a valuation that appears fair rather than clearly cheap or expensive.

Positive Factors
Conservative Balance SheetLow and declining leverage gives the company a meaningful financial cushion and reduces pressure from debt servicing. A stronger equity base also supports resilience through operating volatility, preserves capacity for investment, and improves flexibility in future capital allocation.
Negative Factors
Revenue ContractionA declining revenue base creates a durable challenge for maintaining earnings momentum, particularly when profitability is already being assessed against uneven historical results. Continued contraction could limit operating leverage, reduce reinvestment capacity, and weaken the company’s ability to compound profits.

Science (SAG) vs. iShares MSCI United Kingdom ETF (EWC)

-5%0%5%10%15%20%25%30%GB:SAG+5.35%EWC+18.88%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
GBP 224.69M
Dividend Yield
1.81%
Average Volume (3M)
51.30K
Price to Earnings (P/E)
16.3
Beta (1Y)
0.10
Revenue Growth
-10.91%
EPS Growth
-50.46%
Country
UK
Employees
521
Sector
Industrials
Sector Strength
63
Industry
Consulting Services

Science Business Overview & Revenue Model

Company Description

Science Group plc is an international consulting firm based in Cambridge, UK, offering specialized science and technology services across the United Kingdom, North America, Europe, and other global markets. The company operates through three main div...

Science Financial Statement Overview

Summary

Strong profitability, rising equity, and declining leverage support a solid financial profile, but recent revenue softness and volatility in profit, free cash flow growth, and return on equity temper the score.

Income Statement

78Positive

Balance Sheet

83Very Positive

Cash Flow

75Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue101.70M111.66M110.67M113.34M86.30M81.22M
Gross Profit44.81M46.04M45.18M46.25M38.35M35.36M
EBITDA22.67M22.35M21.13M15.15M16.64M16.00M
Net Income14.59M33.27M12.02M5.52M10.55M9.56M
Balance Sheet
Total Assets150.77M163.42M141.09M132.45M127.28M115.94M
Cash, Cash Equivalents and Short-Term Investments70.38M75.01M41.45M32.83M46.51M37.19M
Total Debt13.65M14.22M15.49M16.90M16.02M16.88M
Total Liabilities57.37M60.11M57.09M54.46M49.08M49.64M
Stockholders Equity93.40M103.32M84.00M77.99M78.20M66.29M
Cash Flow
Free Cash Flow13.01M24.55M18.48M7.83M15.18M9.15M
Operating Cash Flow13.01M24.59M18.48M7.91M15.27M14.01M
Investing Cash Flow1.28M25.28M723.00K-12.78M-34.00K-19.08M
Financing Cash Flow-28.50M-15.98M-10.72M-8.49M-6.46M13.08M

Science Technical Analysis

Technical Analysis SentimentNegative
Last Price554.00

Price Trends

50DMA572.00Negative
100DMA577.01Negative
200DMA565.45Negative

Market Momentum

MACD-1.67Positive
RSI13.57Positive
STOCH36.99Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SAG, the sentiment is Negative. The current price of 554.00 is below the 20-day moving average (MA) of 569.00, below the 50-day MA of 572.00, and below the 200-day MA of 565.45, indicating a bearish trend. The MACD of -1.67 indicates Positive momentum. The RSI at 13.57 is Positive, neither overbought nor oversold. The STOCH value of 36.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:SAG.

Science Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

GB:SAG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GB:SAGGB:SAG76OutperformGBP 221.80M16.2914.83%1.81%-10.91%-50.46%
GB:ELIXGB:ELIX72OutperformGBP 249.15M11.5114.24%4.57%28.85%9.91%
GB:FNTLGB:FNTL65NeutralGBP 189.63M24.967.29%2.12%-3.41%22.52%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
GB:GTLYGB:GTLY63NeutralGBP 92.00M29.784.61%7.91%8.23%118.63%
GB:MANOGB:MANO58NeutralGBP 12.40M11.322.62%―-7.28%22.55%

* Industrials Sector Average

Performance Comparison

-60%-40%-20%0%20%GB:SAGGB:GTLYGB:MANOGB:ELIXGB:FNTLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
GB:SAG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:SAGScience Group plc554.0018.323.42%
GB:GTLYGateley (Holdings)67.00-43.58-39.41%
GB:MANOManolete Partners Plc28.20-61.80-68.67%
GB:ELIXElixirr International Plc495.00-263.93-34.78%
GB:FNTLFintel PLC182.00-24.61-11.91%

Science Corporate Events

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float With Targeted Share Buyback

Neutral
Oct 22, 2026

Science Group plc has executed a small share buyback, acquiring 10,000 ordinary shares at 568.5 pence each via Panmure Liberum Limited and holding them in treasury. The transaction represents 0.02% of prior voting rights and forms part of the group’s...

Stock BuybackRegulatory Filings and Compliance

Science Group updates share capital after latest buyback

Neutral
Oct 21, 2026

Science Group plc has repurchased 10,000 of its 1 pence ordinary shares at an average price of 570 pence, with the entire transaction executed through Panmure Liberum Limited. The shares, representing about 0.02% of prior voting rights, will be held...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Repurchases Shares and Updates Voting Capital

Neutral
Oct 20, 2026

Science Group plc has repurchased 12,500 of its 1 pence ordinary shares at an average price of 570 pence per share, with the transaction executed on 19 October 2026 through Panmure Liberum Limited. The buyback represents about 0.03% of the prior voti...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Adjusts Share Capital with Targeted Buyback

Positive
Oct 19, 2026

Science Group plc has repurchased 10,000 of its own ordinary shares at 570 pence each, representing around 0.02% of the company’s voting rights before the transaction, as part of its ongoing share buyback activity. The shares, acquired via Panmure Li...

Stock BuybackRegulatory Filings and Compliance

Science Group Updates Share Capital After Latest Buyback

Neutral
Oct 16, 2026

Science Group plc has continued its share buyback activity, purchasing 10,000 ordinary shares at 570 pence each on 15 October 2026 through Panmure Liberum Limited. The acquired shares, representing about 0.02% of existing voting rights, will be held...

Stock BuybackRegulatory Filings and Compliance

Science Group Buyback Lifts Executive Chair’s Stake to 20%

Positive
Oct 14, 2026

Science Group plc has repurchased 13,000 ordinary shares at 567 pence each, representing 0.03% of existing voting rights, and placed the shares into treasury, leaving 40,213,093 ordinary shares in issue excluding treasury holdings. Following this tra...

Stock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float With Targeted Share Buyback

Neutral
Oct 13, 2026

Science Group plc has executed a small share repurchase, acquiring 10,000 ordinary shares of 1 pence each at an average price of 568 pence, with Panmure Liberum Limited handling the transaction. The purchase represents about 0.02% of existing voting...

Stock BuybackRegulatory Filings and Compliance

Science Group Adjusts Capital Structure With Targeted Share Buyback

Neutral
Oct 9, 2026

Science Group plc has executed a small share buyback, purchasing 10,000 ordinary shares at 566 pence each on 8 October 2026 through Panmure Liberum Limited. The transaction represents about 0.02% of pre-purchase voting rights, with all acquired share...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Expands Treasury Stock with Targeted Share Buyback

Positive
Oct 6, 2026

Science Group plc has executed a share buyback transaction, purchasing 13,000 ordinary shares at an average price of 566 pence via Panmure Liberum Limited. The repurchased shares, representing 0.03% of prior voting rights, will be held in treasury, l...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Refines Capital Structure with Targeted Share Buyback

Positive
Oct 5, 2026

Science Group plc has repurchased 13,000 of its 1 pence ordinary shares at an average price of 570 pence per share, with the entire transaction executed via Panmure Liberum Limited. The buyback, representing about 0.03% of the company’s voting rights...

Stock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float With Treasury Share Buyback

Neutral
Oct 2, 2026

Science Group plc has repurchased 13,000 of its 1 pence ordinary shares at an average price of 570 pence per share, with all trades executed on AIM through Panmure Liberum Limited. The shares, representing 0.03% of pre-transaction voting rights, will...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Buys Back Shares, Updates Capital Structure and Voting Base

Positive
Oct 1, 2026

Science Group plc has executed a small share buyback, purchasing 13,000 of its 1 pence ordinary shares at an average price of 570 pence, with all trades conducted through Panmure Liberum Limited. The acquired shares, representing about 0.03% of prior...

Business Operations and StrategyRegulatory Filings and Compliance

Science Group Adjusts Share Capital Following Option Exercise

Neutral
Sep 30, 2026

Science Group plc has issued 5,000 treasury shares at a price of 1 pence per share to settle the exercise of employee share options. Following this transaction, the company’s capital structure now comprises 40,298,093 ordinary shares in issue, exclud...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float with Treasury Share Buyback

Neutral
Sep 29, 2026

Science Group plc has repurchased 10,000 of its 1 pence ordinary shares at an average price of 572 pence, representing 0.02% of the voting rights prior to the transaction. The shares, bought through Panmure Liberum Limited, will be held in treasury,...

Stock BuybackRegulatory Filings and Compliance

Science Group Executes Targeted Share Buyback and Updates Share Capital

Neutral
Sep 24, 2026

Science Group plc has executed a small share buyback, acquiring 20,000 of its 1 pence ordinary shares at an average price of 572.5 pence through Panmure Liberum Limited. The transaction represents 0.05% of the company’s voting rights and the purchase...

Stock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float With Targeted Share Buyback

Neutral
Sep 21, 2026

Science Group plc has continued its active capital management programme with a small share repurchase executed on 18 September 2026. The AIM‑quoted science and technology consultancy bought back 10,000 ordinary shares at 572 pence each via Panmure Li...

Stock Buyback

Science Group boosts treasury stock with targeted share buyback

Neutral
Sep 15, 2026

Science Group plc has executed a share buyback transaction, purchasing 20,000 of its 1 pence ordinary shares at an average price of 572 pence through Panmure Liberum Limited, with all shares bought at the same price. The repurchased shares, represent...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Tightens Capital Base with Targeted Share Buyback

Neutral
Sep 11, 2026

Science Group plc has executed a small share repurchase, buying 5,000 ordinary shares at 575 pence each through Panmure Liberum Limited. The purchased shares, representing 0.01% of pre-transaction voting rights, will be held in treasury, reflecting t...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Updates Share Count After Treasury Share Buyback

Positive
Sep 9, 2026

Science Group plc has continued its share buyback activity, purchasing 20,000 ordinary shares on 8 September 2026 at an average price of 577 pence per share through Panmure Liberum Limited. The transaction represents 0.05% of pre-purchase voting righ...

Stock BuybackRegulatory Filings and Compliance

Science Group Tightens Capital Structure With New Share Buyback

Neutral
Sep 7, 2026

Science Group plc, listed on AIM under the ticker SAG, operates as a technology and science-focused company in the U.K. equity market. Its ordinary shares are actively traded on the AIM exchange, and the company manages part of its capital structure...

Business Operations and StrategyStock Buyback

Science Group Boosts Treasury Stock with Targeted Share Buyback

Positive
Sep 3, 2026

Science Group plc has executed a share buyback, acquiring 15,000 of its 1 pence ordinary shares at an average price of 577 pence per share through Panmure Liberum Limited. The transaction, representing 0.04% of prior voting rights, forms part of the...

Business Operations and StrategyRegulatory Filings and Compliance

Science Group Updates Share Capital After Treasury Share Issuance

Neutral
Sep 3, 2026

Science Group plc has issued 15,000 treasury shares at a price of 1 pence per share to satisfy the exercise of employee share options, adjusting its capital structure while utilising existing treasury stock. Following this transaction, the company no...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Tightens Free Float With Targeted Share Buyback

Neutral
Sep 2, 2026

Science Group plc has repurchased 20,000 of its 1 pence ordinary shares at an average price of 578 pence per share, representing 0.05% of the voting rights prior to the transaction. The buyback, executed through Panmure Liberum Limited, reflects ongo...

Regulatory Filings and Compliance

Science Group Updates Share Capital and Voting Rights Structure

Neutral
Sep 1, 2026

Science Group plc has reported that its total issued share capital, excluding treasury shares, stands at 40,418,093 ordinary shares of 1 penny each, while it holds 5,767,781 shares in treasury. This disclosure enables shareholders to calculate whethe...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Boosts Treasury Stock with Targeted Share Buyback

Positive
Aug 27, 2026

Science Group plc has executed a share buyback transaction, purchasing 7,000 of its 1 pence ordinary shares at an average price of 577 pence per share through Panmure Liberum Limited, with all shares to be held in treasury. The repurchase, representi...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Tightens Capital Structure With Targeted Share Buyback

Positive
Aug 26, 2026

Science Group plc has executed a share buyback, purchasing 15,000 ordinary shares at 579 pence each through Panmure Liberum Limited, and holding the acquired stock in treasury. The transaction represents 0.04% of prior voting rights and leaves 40,425...

Business Operations and StrategyRegulatory Filings and Compliance

Science Group Updates Share Count Following Treasury Share Issuance

Neutral
Aug 26, 2026

Science Group plc disclosed that it has issued 5,000 treasury shares at a price of 1 pence per share to satisfy the exercise of employee share options. Following this transaction, the company now has 40,440,093 ordinary shares in issue excluding trea...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Adjusts Share Capital with Targeted Buyback

Neutral
Aug 25, 2026

Science Group plc has executed a small share repurchase, buying 15,000 of its 1 pence ordinary shares at an average price of 579.5 pence, representing 0.04% of the voting rights prior to the transaction. The shares, acquired through Panmure Liberum L...

Stock BuybackRegulatory Filings and Compliance

Science Group Updates Share Count After Treasury Buyback

Neutral
Aug 21, 2026

Science Group plc has continued its capital management strategy by repurchasing 14,000 ordinary shares at an average price of 578 pence, representing 0.03% of the voting rights previously in issue. The shares were acquired on 20 August 2026 through P...

Business Operations and StrategyStock Buyback

Science Group Adds to Treasury Stock with Targeted Share Buyback

Positive
Aug 20, 2026

Science Group plc has conducted a small share buyback, acquiring 20,000 ordinary shares at 578 pence each on 19 August 2026 through Panmure Liberum, representing 0.05% of the company’s voting rights before the transaction. The repurchased shares will...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Buys Back Shares, Updates Capital Structure

Neutral
Aug 19, 2026

Science Group plc has executed a share buyback transaction, repurchasing 15,000 ordinary shares of 1 pence each at an average price of 578 pence per share through Panmure Liberum Limited. The shares, representing about 0.04% of existing voting rights...

Stock BuybackRegulatory Filings and Compliance

Science Group Buys Back Shares, Updates Free Float and Treasury Holdings

Neutral
Aug 18, 2026

Science Group plc has repurchased 20,000 of its 1 pence ordinary shares at an average price of 576.5 pence per share, with the buyback executed through Panmure Liberum Limited on 17 August 2026. The transaction, representing 0.05% of prior voting rig...

Stock BuybackRegulatory Filings and Compliance

Science Group Adjusts Share Capital with Latest Buyback

Neutral
Aug 14, 2026

Science Group plc, a science and technology-focused business listed on AIM, has an established presence in public markets through its ordinary shares. The company holds a sizeable number of shares in treasury, reflecting an active approach to capital...

Stock BuybackRegulatory Filings and Compliance

Science Group Adjusts Share Capital Through Treasury Buyback

Neutral
Aug 12, 2026

Science Group plc has repurchased 10,000 of its 1 pence ordinary shares at an average price of 577 pence per share in a transaction executed on AIM through Panmure Liberum Limited. The buyback represents 0.02% of the prior voting rights and the share...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Buys Back Shares, Updates Treasury and Share Count

Positive
Aug 11, 2026

Science Group plc has executed a small share buyback, purchasing 20,000 of its 1 pence ordinary shares at an average price of 580 pence, with all trades conducted through Panmure Liberum Limited. The repurchased shares, representing about 0.05% of pr...

Business Operations and StrategyStock BuybackRegulatory Filings and Compliance

Science Group Expands Share Buyback and Updates Share Capital Structure

Positive
Aug 10, 2026

Science Group plc has continued its programme of buying back its own shares, acquiring 18,500 ordinary shares at an average price of 580 pence each on 7 August 2026 through Panmure Liberum Limited. The transaction, representing 0.05% of pre-purchase...

Stock BuybackRegulatory Filings and Compliance

Science Group Adjusts Share Capital Structure With New Buyback

Neutral
Aug 7, 2026

Science Group plc has repurchased 20,000 of its 1 pence ordinary shares at an average price of 580.25 pence per share through Panmure Liberum Limited, representing 0.05% of the company’s voting rights prior to the transaction. The shares will be held...

Business Operations and StrategyRegulatory Filings and Compliance

Science Group Updates Share Capital After Treasury Share Option Exercise

Neutral
Aug 7, 2026

Science Group plc has issued 5,000 treasury shares at a price of 1 pence per share to satisfy the exercise of employee share options. Following this transaction, the company now has 40,607,593 ordinary shares in issue excluding treasury shares, while...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 24, 2026